Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ITRAQ analysis of immortalized mouse Schwann cells treated with Ixazomib

ABSTRACT: To determine differentially expressed proteins upon treatment with proteasome inhibitor, Ixazomib, in cultured mouse Schwann cells

ORGANISM(S): Mus Musculus (mouse)

SUBMITTER: Kazunori Sango

PROVIDER: PXD036003 | JPOST Repository | Sat Sep 24 00:00:00 BST 2022

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	A20035_210209E1_1uL_85min_016.wiff	Wiff
	A20035_210209E1_1uL_85min_016.wiff.scan	Wiff
	A20035_210209E2_1uL_85min_004.wiff	Wiff
	A20035_210209E2_1uL_85min_004.wiff.scan	Wiff
	A20035_210209E3_1uL_85min_007.wiff	Wiff

Items per page:

1 - 5 of 12

Similar Datasets

RNA seq of HGPS treated cells

Project description:Evaluation of transcript levels in HGPS cells upon treatment with proteasome inhibitor

2017-06-18 | E-MTAB-5807 | biostudies-arrayexpress

Homo sapiens

Project description:Identification differentially expressed genes upon valproic acid treatment

| PRJNA143291 | ENA

Proteomic analysis to identify altered proteins asoociated with different molecular pathways from livers of mice treated with ibuprofen

Project description:Ibuprofen, an inhibitor of prostanoid biosynthesis is the most common pharmacological agent used for the management of pain, inflammation and fever. However, the chronic use of ibuprofen at high doses is associated with increased risk for cardiovascular, renal, gastrointestinal and liver injuries. The underlying mechanisms of ibuprofen-mediated effects on mice liver and proteasome function remain unclear. To determine the mechanisms and pathways affected by ibuprofen treatment (100mg/kg for 7 days), we performed proteomic profiling of male mice liver with quantitative LC-MS/MS using ten-plex tandem mass tag (TMT) labeling. More than 300 proteins were significantly altered between the control and ibuprofen-treated groups. Independent validation of proteomic data by Western blotting was carried out on 14 proteins using both male and female samples. Additional proteasome and immunoproteasome activity/expression was assayed to evaluate differences in proteasome function between male and female mice liver. Our data suggests that these differentially expressed proteins were found to be associated with several major pathways including (1) energy metabolism, (2) protein degradation, (3) fatty acid synthesis and (4) anti-oxidant system. The study suggests that the sex-related differences in the energy metabolism and proteasome dysfunction are underlying mechanisms for ibuprofen-mediated effects in mice liver and provide insights on novel molecular targets for future drug discovery and development.

2019-06-17 | MSV000083987 | MassIVE

Project description:To determine the differentially expressed genes in cancer associated fibroblasts upon knockdown of ACLP.

| PRJNA843896 | ENA

Trypanosoma brucei brucei

Project description:Differentially expressed genes upon TbSAC3 depletion

| PRJNA316977 | ENA

Homo sapiens

Project description:Genes differentially expressed upon CHD8 knockdown

| PRJNA106441 | ENA

Transcriptional regulation in MCF-7 breast cancer cells treated with proteasome inhibitor MG132 [rna_polii_chIP-seq]

Project description:We report whole genome chromatin immunoprecipitation followed by sequencing (ChIP-seq) of 3 different RNA Pol II CTD modifications in MCF-7 breast cancer cells treated with vehicle (UNTR) or the proteasome inhibitor MG132 for 4 (MG4H) or 24 (MG24H) hours. We find the non-phosphorylated form of RNA Pol II CTD accumulates at TSS of all expressed genes in proteasome inhibited cells, particularly after 24H of MG132 treatment. Proteasome inhibition enhances Ser5-P and Ser2-P binding at TSS of genes induced by MG132. We note that proteasome inhibition establishes unique Ser2-P 5’ to 3’ gene profiles at induced compared to repressed genes. Overall proteasome inhibition enhances RNA Pol II processivity and expression of gene networks relevant to breast cancer. The study provides a comprehensive resource of RNA Pol II binding in proteasome inhibited cells.

2020-01-07 | GSE142010 | GEO

Expression data from MCF7 cells treated with hits from screening cytotoxic michael acceptors

Project description:We used a chemical library to screen for cytotoxic compounds with Michael acceptor groups that induce a cellular response characteristic of proteasome inhibition. We then determined the differentially expressed genes in MCF7 cells following treatment with each of the identified hits This dataset includes expression data from MCF7 cells treated with either DMSO or one of the treatment compounds

2022-02-17 | GSE193542 | GEO

Expression data from lung SCC treated with DMSO and PXD101

Project description:We used microarrays to detail the global programme of gene expression in lung SCC cells treated with belinostat, a pan-HDAC inhibitor. The primary focus of this work is to investigate the efficacy of belinostat on lung SCC cells. Our phosphoproteomic profiling analyses revealed the downregulation of MAPK signaling pathway upon drug treatment, together with the induction of apoptosis. While HDAC inhibition generally affects transcription, the mechanism of SOS/MAPK downregulation was therefore proposed to be affected at the transcriptomic level. However, genes related to MAPK pathway were not significantly regulated upon belinostat treatment, whereas ubiquitin-proteasome gene signature was affected. This supports an indirect mechanism of epigenetic regulation on MAPK signaling that should be explored further.

2017-08-31 | GSE85979 | GEO

Homo sapiens

Project description:Identification of differentially expressed genes upon treatment with Eltrombopag in HL60 cells

| PRJNA161883 | ENA